Encore Global Management LP Purchases Shares of 10,800 SPDR S&P Biotech ETF $XBI

Encore Global Management LP purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,800 shares of the exchange traded fund’s stock, valued at approximately $1,379,000.

A number of other large investors also recently modified their holdings of the company. Avoro Capital Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $256,053,000. Wells Fargo & Company MN increased its position in SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp increased its position in SPDR S&P Biotech ETF by 42,425.2% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after purchasing an additional 1,187,907 shares in the last quarter. Morgan Stanley raised its holdings in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after buying an additional 882,718 shares during the period. Finally, Assetmark Inc. raised its holdings in SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after buying an additional 635,782 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.5%

Shares of XBI stock opened at $149.78 on Wednesday. The stock has a market cap of $10.09 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $165.71. The firm’s 50 day moving average price is $145.16 and its two-hundred day moving average price is $133.90.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.